BonafedeMMMillerJDLaughlin-TommasoSKLukesASMeyerNMLenhartGM. Retrospective database analysis of clinical outcomes and costs for treatment of abnormal uterine bleeding among women enrolled in US Medicaid programs. Clinicoecon Outcomes Res. 2014;6:423–429.
2.
MarjoribanksJLethabyAFarquharC. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst Rev. 2006;(2):CD003855.
3.
GirlingJELockhartMGOlshanskyM. Differential gene expression in menstrual endometrium from women with self-reported heavy menstrual bleeding. Reprod Sci. 2016: 24(1):28–46.
4.
ReisFMNascimentoLLTsigkouAFerreiraMCLuisiSPetragliaF. Activin A and follistatin in menstrual blood: low concentrations in women with dysfunctional uterine bleeding. Reprod Sci. 2007;14(4):383–389.
5.
LockwoodCJKrikunGHickeyMHuangSJSchatzF. Decidualized human endometrial stromal cells mediate hemostasis, angiogenesis, and abnormal uterine bleeding. Reprod Sci. 2009;16(2):162–170.
6.
PakrashiTTaylorJENelsonAArcherDFJacotT. The effect of levonorgestrel on fibrinolytic factors in human endometrial endothelial cells. Reprod Sci. 2016;23(11):1536–1541.
7.
WangRNGreenJWangZ. Bone Morphogenetic Protein (BMP) signaling in development and human diseases. Genes Dis. 2014;1(1):87–105.
8.
SinclairDCMastroyannisATaylorHS. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3. J Clin Endocrinol Metab. 2011;96(2):412–421.
9.
RichardsEGEl-NasharSASchoolmeesterJK. Abnormal uterine bleeding is associated with increased BMP7 expression in human endometrium. Reprod Sci. 2017;24(5):671–681.
